Agilent Technologies (NYSE:A) Lifted to “Strong-Buy” at StockNews.com

StockNews.com upgraded shares of Agilent Technologies (NYSE:AGet Rating) from a buy rating to a strong-buy rating in a research report sent to investors on Wednesday morning.

Other research analysts have also recently issued research reports about the stock. Robert W. Baird boosted their price objective on shares of Agilent Technologies from $155.00 to $161.00 and gave the company an outperform rating in a report on Wednesday, May 25th. Wells Fargo & Company decreased their price objective on shares of Agilent Technologies from $160.00 to $130.00 and set an equal weight rating for the company in a report on Monday, April 25th. The Goldman Sachs Group decreased their price objective on shares of Agilent Technologies from $170.00 to $140.00 and set a buy rating for the company in a report on Thursday, July 14th. Truist Financial cut shares of Agilent Technologies from a buy rating to a hold rating in a report on Tuesday, April 19th. Finally, KeyCorp decreased their price objective on shares of Agilent Technologies from $195.00 to $155.00 and set an overweight rating for the company in a report on Thursday, June 2nd. Four analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Agilent Technologies currently has a consensus rating of Moderate Buy and an average target price of $152.75.

Agilent Technologies Trading Down 0.1 %

Shares of NYSE A opened at $133.61 on Wednesday. Agilent Technologies has a 1-year low of $112.52 and a 1-year high of $179.57. The company has a market cap of $39.91 billion, a PE ratio of 32.20, a P/E/G ratio of 2.76 and a beta of 1.06. The company has a current ratio of 2.01, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53. The company has a 50-day moving average of $122.69 and a two-hundred day moving average of $127.85.

Agilent Technologies (NYSE:AGet Rating) last announced its earnings results on Tuesday, May 24th. The medical research company reported $1.13 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.02. The company had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.62 billion. Agilent Technologies had a net margin of 19.35% and a return on equity of 27.42%. The company’s revenue was up 5.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.97 earnings per share. As a group, equities analysts expect that Agilent Technologies will post 4.88 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 27th. Shareholders of record on Tuesday, July 5th were given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 0.63%. The ex-dividend date was Friday, July 1st. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.24%.

Insiders Place Their Bets

In other Agilent Technologies news, VP Padraig Mcdonnell sold 1,000 shares of the company’s stock in a transaction on Thursday, June 30th. The shares were sold at an average price of $118.62, for a total transaction of $118,620.00. Following the sale, the vice president now directly owns 17,826 shares of the company’s stock, valued at $2,114,520.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, VP Padraig Mcdonnell sold 1,000 shares of the stock in a transaction dated Thursday, June 30th. The shares were sold at an average price of $118.62, for a total value of $118,620.00. Following the transaction, the vice president now directly owns 17,826 shares of the company’s stock, valued at $2,114,520.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Jacob Thaysen sold 5,879 shares of the stock in a transaction dated Thursday, June 2nd. The shares were sold at an average price of $127.43, for a total transaction of $749,160.97. Following the completion of the transaction, the vice president now directly owns 88,737 shares in the company, valued at $11,307,755.91. The disclosure for this sale can be found here.

Hedge Funds Weigh In On Agilent Technologies

Hedge funds have recently bought and sold shares of the business. Associated Banc Corp boosted its position in shares of Agilent Technologies by 2.9% during the fourth quarter. Associated Banc Corp now owns 2,554 shares of the medical research company’s stock valued at $408,000 after buying an additional 72 shares during the last quarter. Glassman Wealth Services boosted its position in Agilent Technologies by 47.4% in the fourth quarter. Glassman Wealth Services now owns 230 shares of the medical research company’s stock worth $37,000 after purchasing an additional 74 shares during the last quarter. Baker Avenue Asset Management LP boosted its position in Agilent Technologies by 0.3% in the second quarter. Baker Avenue Asset Management LP now owns 28,215 shares of the medical research company’s stock worth $3,351,000 after purchasing an additional 78 shares during the last quarter. CWM LLC boosted its position in Agilent Technologies by 1.7% in the second quarter. CWM LLC now owns 4,890 shares of the medical research company’s stock worth $581,000 after purchasing an additional 81 shares during the last quarter. Finally, CENTRAL TRUST Co raised its stake in shares of Agilent Technologies by 4.0% in the fourth quarter. CENTRAL TRUST Co now owns 2,111 shares of the medical research company’s stock worth $337,000 after buying an additional 82 shares during the period.

Agilent Technologies Company Profile

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Read More

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.